BackNKGen Biotech- Warrants (01/09/2028) Overview

NKGen Biotech- Warrants (01/09/2028) Long Term Debt

Track NKGen Biotech- Warrants (01/09/2028)'s long-term debt ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$11.28M
↑ 11.20% YoYΔ $1.14M vs prior year quarter

Peer trimmed avg / median

Loading

NKGen Biotech- Warrants (01/09/2028) Long Term Debt History

Loading

NKGen Biotech- Warrants (01/09/2028) vs. peers: Long Term Debt Comparison

Loading

NKGen Biotech- Warrants (01/09/2028) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NKGen Biotech- Warrants (01/09/2028) (NKGNW) FAQ

NKGen Biotech- Warrants (01/09/2028) posts a long-term debt of $11M as of March 2025. That compares with $10M in the prior-year period — up 11.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NKGen Biotech- Warrants (01/09/2028)'s long-term debt was $10M. The latest reading is $11M — a 11.2% year-over-year increase (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of NKGen Biotech- Warrants (01/09/2028)'s financial statement story. At $11M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NKGNW's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NKGen Biotech- Warrants (01/09/2028)'s other metric pages and overview cover the third.